BioWorld MedTech

April 30, 2013

Deals roundup: Bayer to acquire Conceptus for $1.1B, via tender offer

Bayer Healthcare (Leverkusen, Germany) said it has signed a merger agreement with Conceptus (Mountain View, California), the developer of the Essure procedure, a non-surgical permanent birth control method, for $1.1 billion. Read More

CVRx obtains FDA nod to start Barostim neo hypertension study

Report from Europe: CircuLite gets final results on Synergy CE mark study

Washington roundup: Defibrillators, spinal fusion, radiotherapy win IPPS draft

Financings roundup: RainDance closes $20M Series E funding round

Court report: AirStrip, mVisum settle suit over physiological data

Agreements/contracts: GenomeDx Biosciences expands Mayo collaboration

Medical Device Daily presents a brand-new webinar

HIT roundup: Johns Hopkins to participate in PathCentral Pathology network

Med-Tech Notes

Product Briefs

People in the News

MDD's Cardio Extra

Today's news in brief

BioWorld

BioWorld briefs for Dec. 24, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 23, 2025.

Illustration of magnifying glass looking at cancer in the brain

Researchers discover how glioblastoma tumors dodge chemotherapy

BioWorld MedTech

Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...

Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

HIV research is close to a cure but far from ending the pandemic

BioWorld

Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...

Big pharma taps fast Asia innovation in search of next Keytruda

BioWorld

Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...